| NHANES | National Health and Nutrition Examination Survey |
| HPLC | High-performance liquid chromatography |
| LC-MS/MS | Liquid chromatograph–tandem mass spectrometry |
| ELISA | Enzyme-linked immunosorbent assay |
| HPLC-MS/MS | High-performance liquid chromatography–tandem mass spectrometry |
| IDMS | Isotope dilution mass spectrometry |
| HPLC-FLD | High-performance liquid chromatography–fluorescence detector |
| RR | Relative risk |
| CI | Confidence interval |
| HBV | Hepatitis B virus |
| OR | Odds ratio |
| HCC | Hepatocellular carcinoma |
| GBD | Gallbladder cancer |
| ABC | Adenosine triphosphate-binding cassette |
| EHBDC | Extrahepatic bile duct cancer |
| SPIR | Standardized proportional incidence ratio |
| IHBDC | Intrahepatic bile duct cancer |
| SMR | Standardized mortality ratio |
| CYP450 | Cytochrome 450 |
| AFBO | Aflatoxin B1-exo 8,9-epoxide |
| HCV | Hepatitis C virus |
| CAP | Cold atmospheric plasma |
| AI | Artificial intelligence |
| NIH | National Institutes of Health |